# 1C123891

# 510(k) Summary

# Submitter Name:

Spartan Bioscience Inc.

Address:

Suite 204, 6 Gurdwara Rd Ottawa, Ontario, Canada K2E 8A3 1 (613) 228-7756

# Contact:

Dr. Chris Harder VP Diagnostics

# Phone:

1 (613) 228-7756

AUG 1 2 2013

E-mail:

chris.harder@spartanbio.com

# Date Prepared:

Aug 9th, 2013

Device Trade Name:

Spartan RX™ CYP2C19 System For the assay: Spartan RX CYP2C19 Assay For the platform: Spartan RX CYP2C19 Platform

# Device Common Name:

Drug metabolizing enzyme genotyping assay

Measurand:

CYP450 2C19 \*2, \*3, \*17

Sample Type:

DNA from buccal cells

Technology:

Polymerase Chain Reaction (PCR)

Device Panel:

Chemistry and Toxicology

Classification Name:

Drug metabolizing enzyme genotyping system, 862.3360   
Instrumentation for clinical multiplex test systems, 862.2570

Classification Code:

NTI: Drug metabolizing enzyme genotyping system NSU: Instrumentation for clinical multiplex test systems

Predicate Device:

INFINITI CYP2C19 Assay, 510(k) Number K101683 Classification Code: NTI and NSU, Regulation No. 862.3360 and 862.2570

# Intended Use

The Spartan RX CYP2C19 System is a qualitative in vitro diagnostic test for the identification of a patient's CYP2C19 $\bullet 2$ $^ { \star } 3$ and $\yen 17$ genotype determined from genomic DNA obtained from a buccal swab sample. For prescription use only.

Indication for Use

Spartan RX CYP2C19 Assay - The Spartan RX CYP2C19 System is indicated for use as an aid to clinicians in determining therapeuticstrategies for therapeutics that are metabolized by the Cytochrome P450 2C19 gene product, and that are specifically affected by the $^ { \star } 2 , ~ 3 ,$ and $\yen 17$ alleles. The Spartan RX CYP2C19 Assay will be run on the Spartan RX CYP2C19 Plaform from the buccal sample collected with a buccal swab. The Spartan RX CYP2C19 Assay is not indicated to be used to predict drug response or non-response.

Spartan RX CYP2C19 Platform - The Spartan RX CYP2C19 System is indicated for use as an aid to clinicians in determining therapeutic strategies for therapeutics that are metabolized by the Cytochrome P0 2C19 gene product, and that are specifically afected by the , 3, and 17 alleles. The Spartan R CYP2C19 Platform will be used to run the Spartan RX CYP2C19 Assay.

# Device Description

The Spartan RX CYP2C19 System is a sample-to-result DNA testing system that uses proprietary technology to integrate DNA extraction and amplification. Genotypes are determined using PCR and fluorescent probe detection. The Spartan RX CYP2C19 System is comprised of the Spartan RX CYP2C19 Platform and Spartan RX CYP2C19 Assays. The Spartan RX CYP2C19 Assays are run on the Spartan RX CYP2C19 Platform.

The Spartan RX CYP2C19 System is based on the following processes:

i. Buccal swab collection   
ii. DNA extraction   
ii. PCR-based amplification of the target gene   
iv. Detection of the $\star _ { 2 }$ . $\star _ { 3 }$ ,and $\star 1 7$ alleles using fluorescent-probes   
V. Fluorescent signal detection and analysis   
vi. Genotype determination

The Spartan RX CYP2C19 System integrates and automates steps i to vi. Results are presented to the end user as genotype calls. The system also has integrated controls that monitor performance of a run and automatically inform the user of any anomalies in the instrument or reagents.

The system detects the CYP2C19 $\blacktriangleleft$ , $\star 3$ ,and $\yen 17$ genotypes in separate reagent tubes. The operator collects buccal swab samples from a patient; inserts each sample into a reagent tube; and then inserts the reagent tubes into a Spartan RX Analyzer instrument.

# Spartan RX CYP2C19 Platform

There are four components of the Spartan RX CYP2C19 Platform.

a) The SPARTAN RX ANALYZER is a thermal cycling instrument that automates polymerase chaii reaction (PCR) amplification of the target gene, fluorescence-based detection of CYP2C19 alleles, and genotype calling.   
b) The NETBOOK serves as the user interface for logging in to the Spartan RX Platform, inputting patient information, and starting a test.   
c) The PRINTER automatically prints the genotype results after the Spartan RX Platform finishes performing the Spartan RX CYP2C19 Assays.   
d) The BARCODE SCANNER is used to automatically enter SCK and ECK lot numbers into the Spartan RX Platform.

# Spartan RX CYP2C19 Assays

The Spartan RX CYP2C19 Assays are the consumable components of the Spartan RX CYP2C19 System. There are two different types of assay—each type is described in detail below.

a) SAMPLE COLLECTION KITS (SCKs) contain the consumables required to determine a patient's CYP2C1 $\mathfrak { g } { \star } \mathfrak { 2 }$ $^ { \star } 3 .$ ,or $\star 1 7$ genotype. There are three types of SCKs, specific for the $^ { \star 2 }$ $\star 3$ ,or $\star 1 7$ alleles. Each SCK consists of the following components:

POUCH, containing labeling information to ensure traceability (lot number, manufacturing date, and expiry date) and two compartments (for the buccal swab and reagent tube). The pouch also includes a barcode that is compatible with a standard reader.   
BUCCAL SWAB, used to collect a buccal sample from the inside of a patient's cheek and transfer it into the reagent tube.   
REAGENT TUBE, containing chemicals for DNA extraction, PCR amplification, and fluorescent detection of the specific CYP2C19 allele.

The SCKs are color-coded to indicate which CYP2C19 allele they are designed to detect.

BLUE $= { } ^ { \star 2 }$ WHITE $= ^ { \star 3 }$ $B L A C K = ^ { \star } 1 7$

b) EXTERNAL CONTROL KITS (ECKs) contain the consumables required to determine if the Spartan RX Platform and reagents are performing correctly. Each ECK consists of the following components:

POUCH, containing labeling information to ensure traceability (lot number, manufacturing date, and expiry date). REAGENT TUBE, containing synthetic nucleic acid control and chemicals for PCR amplification and fluorescent detection of the specific CYP2C19 allele.

The ECKs are color-coded to indicate which reagent they control for.

BLUE $= { } ^ { \star 2 }$ EY WHITE $= { } ^ { \star } 3$ EPY $B L A C K = 1 7$

The ECKs have been modified so that the tube cannot be opened. They are meant to be put directly into the analyzer without adding or removing anything from them

# Spartan RX Accessories

The SAMPLE TRANSPORT SYSTEM is an insulated transport bag that contains a polystyrene box and a Cold Block. The Transport System is designed to keep the SCKs cold as they are moved from the freezer to the patient and from the patient to the Spartan RX Analyzer. The Transport System is provided with purchase of the platform and is to be used for all tests..

# Substantial Equivalence Discussion

The Spartan RX CYP2C19 System uses the same fundamental scientific technologies, and has a similar intended use, as that of the predicate device—the INFINITI CYP2C19 Assay. The table below provides a comparison of the Spartan RX CYP2C19 System and the predicate device. The comparison demonstrates that the Spartan RX CYP2C19 System is substantially equivalent to the predicate device.

Table 1 - Comparison of the Spartan RX CYP2C19 System to the predicate device   

<table><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Predicate DeviceINFINITI CYP2C19 Assay(K101683)</td><td colspan="1" rowspan="1">Subject DeviceSpartan RX CYP2C19 System</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="2" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The INFINITI CYP2CI9 Assay is an invitro diagnostic test for theidentification of apatient's CYP450 2C19 genotype ingenomic deoxyribonucleic acid (DNA)obtained fromEDTA-anticoagulated whole bloodsamples. The INFINITI CYP2CI9</td><td colspan="1" rowspan="1">The Spartan RX CYP2C19 System is aqualitative in vitro diagnostic test for theidentification of a patient's CYP2C19 *2,*3 and *17 genotype determined fromgenomic DNA obtained from a buccalswab sample. For prescription use only.</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Assay is a qualitativeassay for use in clinical laboratoriesupon prescription by the attendingphysician.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">The INFINITI CYP2C19 AsSay isindicated for use as an aid to cliniciansin determiningtherapeutic strategy for therapeuticsthat are metabolized by the CYP4502C19 gene product,specifically *, , * 17.The INFINITI CYP2CI9 AsSay is notindicated to be used to predict drugresponse or nonresponse.</td><td colspan="1" rowspan="1">Spartan RX CYP2C19 Assay - TheSpartan RX CYP2C19 System isindicated for use as an aid to clinicians indetermining therapeutic strategies fortherapeutics that are metabolized by theCytochrome P450 2C19 gene product,and that are specifically affected by the*2, *3, and *17 alleles. The Spartan RXCYP2C19 Assay will be run on theSpartan RX CYP2C19 Platform fromthe buccal sample collected with abuccal swab. The Spartan RXCYP2C19 Assay is not indicated to beused to predict drug response or non-response.Spartan RX CYP2C19 Platform - TheSpartan RX CYP2C19 System isindicated for use as an aid to clinicians indetermining therapeutic strategies fortherapeutics that are metabolized by theCytochrome P450 2C19 gene product,and that are specifically affected by the*2, *3, and *17 alleles. The Spartan RXCYP2C19 Platform will be used to runthe Spartan RX CYP2C19 Assay.</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Not intended to be used to predict drugresponse or non-response.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">DNA Sequence</td><td colspan="1" rowspan="1">Detects specific DNA sequencesthrough recognition of DNA targetswith fluorescence.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Technology</td><td colspan="1" rowspan="1">Utilizes thermal cycling and targetDNA amplification.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay Results</td><td colspan="1" rowspan="1">Assay signal results are interpreted bya software program.Assay results are provided asgenotype calls reported to the enduser in a report format.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Target Gene</td><td colspan="1" rowspan="1">CYP4502C19 *2, *3, and *17.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td></td><td></td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Purified DNA from EDTA-anti-coaqulated whole blood sample.</td><td colspan="1" rowspan="1">Unpurified DNA from a buccal swabsample.</td></tr><tr><td colspan="1" rowspan="1">Platform</td><td colspan="1" rowspan="1">Microarray-based genotyping test forsimultaneous (multiplex system) ofDNA sequences.</td><td colspan="1" rowspan="1">Fluorescent-probe PCR-basedgenotyping test for multiplex analysis ofDNA sequences.</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Trial Calling Rates</td></tr><tr><td colspan="1" rowspan="1">Reproducibility (%agreement/ 95%Lower Cl</td><td colspan="1" rowspan="1">96.9% / 95.6%</td><td colspan="1" rowspan="1">99.8% / 99.4%</td></tr><tr><td colspan="1" rowspan="1">Method comparison(% agreement/ 95%Lower Cl)</td><td colspan="1" rowspan="1">100.0% / 99.8%</td><td colspan="1" rowspan="1">100.0% / 99.2%</td></tr></table>

# Performance

# Limit of Detection (Analytical Sensitivity)

The input material for the Spartan RX CYP2C19 System is a buccal swab collected from an individual, which is inserteddirectly into the reagent tube without any requirement for the user to extract or puriy A For this reason, he objective o the lmit of detectin (LOD) study was to determie f the Spartan RX CYP2C19 System can function across the range of target material amounts collected in typical buccal swabs. The study was conducted in two parts.

Part 1 involved the determination of a relative measure of the amount of DNA present in 100 individual buccal swabs, collected from 40 different individuals by 11 different operators. These operators had laboratory- and non-laboratory backgrounds. The mean DNA amount was deemed to be equivalent to one "typical" swab and all measurements were normalized to this value and presented as the number of swab equivalents.

Par 2 assessed the analytical sensitivity (limit of detection) by analyzing buccal swab samples collected from \*1/\*1, \*2/17, \*17/\*17, and \*2/3 individuals. Five DNA collection conditions were used: 5 pooled bucal swabs; 2 pooled buccal swabs; a normal buccal swab; a single downward stroke (1 half stroke); and a single touch of the swab to the inside of the mouth.Replicates of 52 samples were performe for each condition.Results are summarized in Tables 2a and 2b.In parallel, the amount of DNA in the swabs was quantified using SYBR Green (standard curve), and this value was translated to the corresponding number of swabs relative to the mean of the population determined in Part 1.

Table 2a  Limit of Detection  FIRST PASS   

<table><tr><td rowspan=1 colspan=1>TestCondition</td><td rowspan=1 colspan=1>Genotype&quot;</td><td rowspan=1 colspan=1>#Samplestested</td><td rowspan=1 colspan=1>#Correctcallsb</td><td rowspan=1 colspan=1>#Incorrectcails</td><td rowspan=1 colspan=1># No calls</td><td rowspan=1 colspan=1>%Correctcalls</td><td rowspan=1 colspan=1>95% One-sidedconfidencelower limit)</td></tr><tr><td rowspan=5 colspan=1>5 pooledswabs</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>84.6%</td><td rowspan=1 colspan=1>63%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>92.3%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>61.5%</td><td rowspan=1 colspan=1>40%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>RM0</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>84.6%</td><td rowspan=1 colspan=1>75%</td></tr><tr><td rowspan=5 colspan=1>2 pooledswabs</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=5 colspan=1>Normal Swab</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>92.3%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>98.1%</td><td rowspan=1 colspan=1>92%</td></tr><tr><td rowspan=5 colspan=1>1 Half Stroke</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>92.3%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>98.1%</td><td rowspan=1 colspan=1>92%</td></tr><tr><td rowspan=5 colspan=1>Inside MouthTouch</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>76.9%</td><td rowspan=1 colspan=1>54%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>92.3%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>69.2%</td><td rowspan=1 colspan=1>46%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>244</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>¤c</td><td rowspan=1 colspan=1>84.6%</td><td rowspan=1 colspan=1>75%</td></tr></table>

Genotyped by bi-directional sequencing: 1/1 samples are wild-type for $^ { \star 2 }$ , $^ { \star 3 }$ , and $\yen 17$ .

<table><tr><td rowspan=1 colspan=1>TestCondition</td><td rowspan=1 colspan=1>Genotype&#x27;</td><td rowspan=1 colspan=1>#Samplestested</td><td rowspan=1 colspan=1>Δ#Correctcalls</td><td rowspan=1 colspan=1>#Incorrectcalls</td><td rowspan=1 colspan=1># No calls</td><td rowspan=1 colspan=1>%Correctcalls</td><td rowspan=1 colspan=1>95% One-sidedconfidencelower limit)</td></tr><tr><td rowspan=5 colspan=1>5 pooledswabs</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>92.3%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*17*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>98.1%</td><td rowspan=1 colspan=1>92%</td></tr><tr><td rowspan=5 colspan=1>2 pooledswabs</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=5 colspan=1>Normal Swab</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=5 colspan=1>1 Half Stroke</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=5 colspan=1>Inside MouthTouch</td><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Iotal</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>95%</td></tr></table>

Genotype by bi-directional sequencing; \*1/1 samples are wild-type for $\blacktriangleleft$ , $\pmb { \mathscr { s } }$ , and \*17. c     y.

The first pass correct call rate at input levels lower than 0.1 swabs per test was 84.6%. Therefore, the lower limit of detection of the Spartan RX CYP2C19 System is 0.1 swabs per test.

![](images/6ac462b03393782c8cf05f86345ab9f351d3ee93ce9f4546753fdead084b4952.jpg)  
Relationship between # Swabs across population & amount of collected material using various swabbing techniques   
Figure 1  Relationship between the normal swab population & the amount of material collected using the various swabbing techniques as outlined in the protocol. The corresponding average amount of genomic DNA (ng) collected using each swabbing technique is indicated on the right side of the graph.

These experiments indicate that there are two consequences when excessively high or low amounts of buccal material are collected. Either the system generates an internal control abort (Positive System Control fail) or the system generates a No call result. To avoid these consequences, the Instructions for Use recommend that operators swab firmly with 3x up-and-down strokes. Based on these results, proper swabbing is an important factor that influences the rateof No call results. Also, the results from Par 3 demonstrated the system's lower limit of detection when using genomic DNA. The recommended quantity of DNA for external controls was based on these results.

# Method Comparison

The Spartan RX CYP2C19 System was compared to bi-directional sequencing. Samples were deidentified o protect patnt dentity. GenoicDA was extracted from saliv samples. I the resul e first test for a particular individual was a No call, the test was repeated (second pass).

The Method Comparison study was performed by 10 operators at three different locations. The operators had no previous swabbing experience. Of the 327 samples tested, sequencing was unsuccessful for 2 samples—these samples were excluded from the analysis. Of the 325 samples included in the analysis, 4 saples gave a No call result on the rst pass test and were e-teste After the second pass, ll samples wer calld correct No samples were called incorrecty.The overall correct call rate or he st pass and second pass tests was $9 8 . 8 \%$ and $100 \%$ , respectively.

For this study, $1 / 3$ of samples collected were tested immediately (4 minutes pre-swabbing and 8 minutes post-swabbing); 1/3 were tested after 10 minutes (4 minutes pre-swabbing and 10 minutes postswabbing); and 1/3 were tested after 60 minutes (45 minutes pre-swabbing and 60 minutes post swabbing) of storage in the Sample Transport System after swab insertion.

Results of first and second pass tests are summarized in Tables 3a and 3b, respectively.

<table><tr><td rowspan=1 colspan=1>Genotype</td><td rowspan=1 colspan=1>#Samplestested</td><td rowspan=1 colspan=1>#CorrectCallsb</td><td rowspan=1 colspan=1>#Incorrectcalls</td><td rowspan=1 colspan=1># No calls</td><td rowspan=1 colspan=1>%Correctcalls</td><td rowspan=1 colspan=1>95% One-sidedconfidencelower limit</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>98.5%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>98.9%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>*2/1*2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>88%</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*3/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>27%</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>80%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>69%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>*3/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>27%</td></tr><tr><td rowspan=1 colspan=1>TOTAL</td><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>321</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>98.8%</td><td rowspan=1 colspan=1>97%</td></tr></table>

Genotype by bi-directional sequencing; \*1/\*1 samples are wild-type for $\blacktriangleleft$ , $\bullet 3$ , and $^ { \star } 1 7$ . In order for a sample to be deemed a correct call, results of all three genotypes $( ^ { \star } 2 , { ^ { \star } 3 } , { ^ { \star } 1 } 7 )$ had to be correct.

Table 3b - Method Comparison - SECOND PASS   

<table><tr><td rowspan=1 colspan=1>Genotype&quot;</td><td rowspan=1 colspan=1>#Samplestested</td><td rowspan=1 colspan=1>#CorrectCallsb</td><td rowspan=1 colspan=1>#Incorrectcalls</td><td rowspan=1 colspan=1>. # No calls</td><td rowspan=1 colspan=1>%Correctcalls</td><td rowspan=1 colspan=1>95% One-sidedconfidencelower limit</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>97%</td></tr><tr><td rowspan=1 colspan=1>*2/*2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>88%</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>72%</td></tr><tr><td rowspan=1 colspan=1>*3/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>27%</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>80%</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>69%</td></tr><tr><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>*3/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>27%</td></tr><tr><td rowspan=1 colspan=1>TOTAL</td><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>99%</td></tr></table>

\* Genotype by bi-directional sequencing; \*1/\*1 samples are wild-type for \*2, \*3, and \*17.

For the Transport System, the first pass results were 109/110, 105/106,107/109 for the immediate, 10 minute and 60 minute time points, respectively. Alresults were 100% on the second pass.

Buccal swab samples were collected from \*1/\*17, \*2/\*3, \*1/\*1, \*17/\*17, \*1/3, \*2/\*17, \*2/2, and \*1/2 individuals (one individual per genotype) across three sites. Genotypes of the eight individuals were confirmed by bi-directional sequencing. Two operators were employed at each site, and tests were performed across five non-consecutive days. Typicaly, operators were laboratory technicians who had no previous experience with swabbing. At one site, two of the operators did not work in the medical or laboratory field. There were two sessions per day (AM and PM), and each session was split into two subsessions. In each sub-session, each of the eight individuals was tested once by Operator 1 and once by Opeator . If the result of the fst test or a particular indiviual wasa No calhe test was eatd (secnd pass). Results of the inter-laboratory reproducibility study are presented in Tables 4a and .

Table 4a - Inter-Laboratory Reproducibility - FIRST PASS   

<table><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>#samplestested</td><td rowspan=1 colspan=1># no calls</td><td rowspan=1 colspan=1>#Incorrectcalls</td><td rowspan=1 colspan=1># correctcalls</td><td rowspan=1 colspan=1>% correctcall rate</td><td rowspan=1 colspan=1>95%ConfidenceLimit</td></tr><tr><td rowspan=4 colspan=1>*1/*1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>98.3%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=4 colspan=1>*1/*2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*2/*2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>95.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>98.3%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=4 colspan=1>*1/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>98.3%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=4 colspan=1>*2/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>92.5%</td><td rowspan=1 colspan=1>83%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>117</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=4 colspan=1>*1/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*17/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>98.3%</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=4 colspan=1>*2/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>TOTAL</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>317</td><td rowspan=1 colspan=1>99.1%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>317</td><td rowspan=1 colspan=1>99.1%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>315</td><td rowspan=1 colspan=1>98.4%</td><td rowspan=1 colspan=1>97%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>960</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>949</td><td rowspan=1 colspan=1>98.9%</td><td rowspan=1 colspan=1>98%</td></tr></table>

Genotype by bi-directional sequencing; $\yen 123,456$ samples are wild-type for $^ { \star 2 }$ $\bullet 3$ , and $\yen 17$ . In order for a sample to be deemed a correct call, results of all three genotypes $( ^ { \star } 2 , { ^ { \star } 3 } , { ^ { \star } 1 } 7 )$ had to be correct.

<table><tr><td rowspan=1 colspan=1>SampleTypea</td><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1># samplestested</td><td rowspan=1 colspan=1># nocalls</td><td rowspan=1 colspan=1>#incorrectcalls</td><td rowspan=1 colspan=1>#correctcalls</td><td rowspan=1 colspan=1>;:% correct callrate</td><td rowspan=1 colspan=1>95%ConfidenceLimit</td></tr><tr><td rowspan=4 colspan=1>*1/*1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>119</td><td rowspan=1 colspan=1>99.2%</td><td rowspan=1 colspan=1>96%</td></tr><tr><td rowspan=4 colspan=1>*1/*2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*2/*2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*1/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*2/*3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>97.5%</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Q</td><td rowspan=1 colspan=1>119</td><td rowspan=1 colspan=1>99.2%</td><td rowspan=1 colspan=1>96%</td></tr><tr><td rowspan=4 colspan=1>*1/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*17/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>*2/*17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>94%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=4 colspan=1>TOTAL</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>99%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>99%</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>318</td><td rowspan=1 colspan=1>99.4%</td><td rowspan=1 colspan=1>99%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>960</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>958</td><td rowspan=1 colspan=1>99.8%</td><td rowspan=1 colspan=1>99%</td></tr></table>

a Genotype by bi-directional sequencing: \*1/1 samples are wild-type for $^ { \bullet 2 }$ , $^ { \star } 3$ , and $\yen 17$ . In order for a sample to be deemed a correct call, results of all three genotypes $( \pm 2 , \pm 3 , \pm 4 7 )$ had to be correct.

Overall, a total of 960 tests were performed—10 second pass tests were perfomed due to No calls on the first pass test, and all but 1 were recovered.

Overall, after second pass testing of No call genotype results, the Spartan RX CYP2C19 System produced a correct call rate of 99.8%, with a 95% one-sided lower confidence limit of 99%.

# Rabgetb Ldnterllat@eptoduB#phityducibility  SECOND PASS

Lot-to-ot reproducibility was assssd usigthreendependent lots  each reagent type labeled s 1, and 3 and performed concurrently with the Site 1 Inter-laboratory Reproducibility study.

On the first pass, 3 samples produced No call results. After the second pass, all of these samples prduced correct results. Overal the results ndicate that dffrent reagent ots perform equivalenty.

First and second pass results for the Reagent Lot-to-Lot Reproducibility study are presented in Tables a and 5b, respectively.

Table 5a  Reagent Lot-to-Lot Reproducibility - FIRST PASS   

<table><tr><td rowspan=1 colspan=1>Reagent Lot</td><td rowspan=1 colspan=1>Genotype</td><td rowspan=1 colspan=1># Samplestested</td><td rowspan=1 colspan=1># Correctcaalls b</td><td rowspan=1 colspan=1>#incorrectcalls</td><td rowspan=1 colspan=1># No calls</td><td rowspan=1 colspan=1>% Correct calls(95% one-sidedconfidence lowerllmit)</td></tr><tr><td rowspan=9 colspan=1>Lot 1</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>85% (63%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=2 colspan=1>93% (73%)97% (93%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>104</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=9 colspan=1>Lot 2</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*2/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=2 colspan=1>100%(98%)100%(84%)</td></tr><tr><td rowspan=9 colspan=1>Lot 3</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*21*2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (98%)</td></tr></table>

a Genotype by bi-directional sequencing; \*1/\*1 samples are wild-type for \*2, \*3, and \*17. In order for a sample to be deemed a correct call, results of all three genotypes $( ^ { \star } 2 , { ^ { \star } 3 } , { ^ { \star } 1 7 } )$ had to be correct.

Table 5b - Reagent Lot-to-Lot Reproducibility - SECOND PASS   

<table><tr><td rowspan=1 colspan=1>Reagent LotA</td><td rowspan=1 colspan=1>:. Genotype</td><td rowspan=1 colspan=1># Samplestested</td><td rowspan=1 colspan=1># Correctcallsb</td><td rowspan=1 colspan=1>#incorrectcalls</td><td rowspan=1 colspan=1># No calls</td><td rowspan=1 colspan=1>% Correct calls(95% one-sidedconfidence lower(imit)</td></tr><tr><td rowspan=9 colspan=1>Lot 1</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=2 colspan=1>100%(84%)100%(98%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>O</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=9 colspan=1>Lot 2</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*17/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(84%)</td></tr><tr><td rowspan=1 colspan=1>*21*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=3 colspan=1>100%(83%)100%(98%)100%(84%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=9 colspan=1>Lot 3</td><td rowspan=1 colspan=1>*2/*17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>*1/*2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%(83%)</td></tr><tr><td rowspan=1 colspan=1>*1/*17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>*17/M17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>*2/*2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (84%)</td></tr><tr><td rowspan=1 colspan=1>*1/*3</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (83%)</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100% (98%)</td></tr></table>

Genotype by bi-directional sequencing; \*1/1 samples are wild-type for $\star _ { 2 }$ , $^ { * 3 }$ , and $\star 1 7$ bIn order for a sample to be deemed a correct call results of all three genotypes $( \times 2 , \times 3 , \times 1 7 )$ had to be correct.

# Exogenous and Endogenous Interfering Substances

Interference from exogenous and endogenous interfering substances was evaluated using buccal swab samples collected from \*1/1, \*2/\*17, \*17/\*17, and \*2/3 individuals. Genotypes of all individuals were confirmed by bi-directional sequencing prior to initiation of the study.

To test the impact of exogenous substances, buccal swab samples were collected from individuals after exposure to the substance. The individuals rinsed with water (as per the Instructions for Use for the Spartan RX CYP2C19 System) before swab collection.

Direct exposure of individuals to endogenous substances was not possible. Therefore, these substances were added directy to the reagent tube immediately prior to insertion of the buccal swab sample. Note that the Instructions for Use require the patient torinse his or her mouth with water prior to colection o the buccal swab sample. The purpose of the water rinse is to remove any contaminating endogenous materials such as blood or blood components. So although certain endogenous substances wil interfere with performance of the Spartan RX CYP2C19 System, this risk is mitigated by the water rinse.

The following exogenous and endogenous substances were tested:

Antiseptic mouthwash . Toothpaste C Baking soda solution • Cough syrup . Cranberry juice . Salt water • Sugar water • Meat • Chewing gum . Hard candy • Tobacco smoking . Denture paste • Human Oral Bacteria • Whole Blood

$2 0 \ m |$ - Rinse around mouth for $\mathtt { 3 0 s }$   
$3 / 4 "$ Strip - Brush teeth for 2 min, spit   
$3 0 ~ \mathsf { m l }$ (0.1 g /ml) - Rinse around mouth for 10 s   
$3 0 m |$ - Rinse around mouth for 10 s   
$3 0 \mathsf { m l }$ - Rinse around mouth for 10 s   
EY $3 0 m 1$ EY $\left( 0 . 0 1 ~ \mathsf { g } / \mathsf { m } \mathsf { l } \right)$ — Rinse around mouth for $1 0 \thinspace \thinspace \thinspace \thinspace \thinspace \thinspace$   
EY $3 0 \mathsf { m l }$ $( 0 . 0 1 ~ \mathsf { g } / \mathsf { m l } )$ - Rinse around mouth for 10 s   
15 g - Chew for 10 s   
1 standard piece - Chew for 1 min   
1 standard piece - Suck until fully dissolved   
1 cigar - 5 puffs   
3 strips - Apply strips to roof of mouth, leave for 5 min,   
remove   
Approximately ${ \mathfrak { s } } \times { \mathfrak { s } } { \mathfrak { d } } ^ { 4 }$ cells (in addition to normal oral flora)   
${ \mathsf { 3 . 5 } } { \mathsf { \mu \updownarrow } }$ of $0 . 5 \%$ blood (diluted in saliva)

A total of 16 samples were tested for each exogenous and endogenous interfering substance $\scriptstyle \mathbf { n } = 4$ per s e l    es  prurvil waa o  e t repeated (second pass).

The results of the Exogenous and Endogenous Interfering Substances study indicate that substances commonly introduced into the oral environment do not affect performance of the Spartan RX CYP2C19 System. Nevertheless, proper rinsing and swabbing techniques must be followed to minimize the rate of No calls associated with inhibiting substances.

Results of first and second pass tests performed during the Exogenous and Endogenous Interfering Substances study are summarized in Tables 6a and 6b, respectively.

Table 6b - Exogenous and Endogenous Interfering Substances - SECOND PASS   

<table><tr><td rowspan=1 colspan=1>Genotype</td><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>Samplestested</td><td rowspan=1 colspan=1>#Correctcallis</td><td rowspan=1 colspan=1>#incorrectcalls</td><td rowspan=1 colspan=1># Nocalls</td><td rowspan=1 colspan=1>% Correctcalls</td><td rowspan=1 colspan=1>95% one-sidedconfidencelower limit</td></tr><tr><td rowspan=15 colspan=1>Combinedgenotyperesults</td><td rowspan=1 colspan=1>Mouthwash</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>93.8%</td><td rowspan=1 colspan=1>76%</td></tr><tr><td rowspan=1 colspan=1>Toothpaste</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>31.3%</td><td rowspan=1 colspan=1>16%</td></tr><tr><td rowspan=1 colspan=1>Baking soda</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>87.5%</td><td rowspan=1 colspan=1>68%</td></tr><tr><td rowspan=1 colspan=1>Cough syrup</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Cranberry juice</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>NaCl solution</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Sugar solution</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Meat (horse)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Chewing qum</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>87.5%</td><td rowspan=1 colspan=1>68%</td></tr><tr><td rowspan=1 colspan=1>Hard candy</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Tobacco (cigar)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>93.8%</td><td rowspan=1 colspan=1>76%</td></tr><tr><td rowspan=1 colspan=1>Denture paste</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Bacteria</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>93.8%</td><td rowspan=1 colspan=1>76%</td></tr><tr><td rowspan=1 colspan=1>Whole blood</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>93.8%</td><td rowspan=1 colspan=1>76%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>224</td><td rowspan=1 colspan=1>205</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>91.5%</td><td rowspan=1 colspan=1>88%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Genotype:</td><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>#Samplestested</td><td rowspan=1 colspan=1># Correctcaalls</td><td rowspan=1 colspan=1>#incorrectcalls</td><td rowspan=1 colspan=1># Nocalls</td><td rowspan=1 colspan=1>% Correctcails</td><td rowspan=1 colspan=1>95% one-sidedconfidencelower limit</td></tr><tr><td rowspan=15 colspan=1>Combinedgenotyperesults</td><td rowspan=1 colspan=1>Mouthwash</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Toothpaste</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1b</td><td rowspan=1 colspan=1>93.75%</td><td rowspan=1 colspan=1>76%</td></tr><tr><td rowspan=1 colspan=1>Baking soda</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Cough syrup</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Cranberry juice</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>NaCl solution</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Sugar solution</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Meat (horse)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Chewing qum</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Hard candy</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Tobacco (cigar)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Denture paste</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Bacteria</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Whole blood</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.00%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>224</td><td rowspan=1 colspan=1>223</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>99.55%</td><td rowspan=1 colspan=1>98%</td></tr></table>

In order for a sample to be deemed a correct call, results of all three genotypes $( \cdot 2 , \cdot 3 , \cdot 1 7 )$ had to be correct. least three minutes before swabbing.

# August 12, 2013

Spartan Bioscience Inc.   
c/o Lorry Huffman   
c/o Myraqua, Inc.   
3 Lagoon Drive, Ste 280   
REDWOOD SHORES CA 94065

Re: K123891 Trade/Device Name: Spartan RXTM CYP2C19 System Regulation Number: 21 CFR 862.3360 Regulation Name: Drug metabolizing enzyme genotyping system Regulatory Class: II Product Code: NTI, NSU Dated: June 28, 2013 Received: July 3, 2013

Dear Ms. Huffman:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2- Ms. Huffman

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/lndustry/default.htm.

Sincerely yours, Carol C. Benson -S for

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

Enclosure

# Indications for Use Form

510(k) Number (if known): _K123891

Device Name:  Spartan RX CYP2C19 System

Indications for Use:

Assay - The Spartan RX CYP2C19 System is indicated for use as an aid to clinicians in determining therapeutic strategies for therapeutics that are metabolized by the Cytochrome P450 2C19 gene product, and that are specifically affected by the $^ { \star 2 }$ , $\yen 3$ , and $^ { \star } 1 7$ alleles. The Spartan RX CYP2C19 Assay will be run on the Spartan RX Platform from the buccal sample collected with a buccal swab. The Spartan RX CYP2C19 Assay is not indicated to be used to predict drug response or non-response.

Platform - The Spartan RX CYP2C19 System is indicated for use as an aid to clinicians in determining therapeutic strategies for therapeutics that are metabolized by the Cytochrome P450 2C19 gene product, and that are specifically affected by the $\star 2$ , $\star 3$ , and $^ { \star } 1 7$ alleles. The Spartan RX CYP2C19 Platform will be used to run the Spartan RX CYP2C19 Assay.

Prescription Use X AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrencef DRH, Officef InVit Diagnostics and Radiological Health OR

Ruth A. Chesler -S